Berry Genomics Co.,Ltd (SHE:000710)
11.10
-0.30 (-2.63%)
Mar 19, 2026, 1:25 PM CST
Berry Genomics Co.,Ltd Market Cap
Berry Genomics Co.,Ltd has a market cap or net worth of 4.03 billion as of March 18, 2026. Its market cap has decreased by -10.02% in one year.
Market Cap
4.03B
Enterprise Value
4.03B
Revenue
941.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.10
Market Cap Chart
Since June 20, 2017, Berry Genomics Co.,Ltd's market cap has decreased from 24.43B to 4.03B, a decrease of -83.50%. That is a compound annual growth rate of -18.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 4.03B | 0.97% |
| Dec 31, 2025 | 3.99B | 33.61% |
| Dec 31, 2024 | 2.99B | -26.65% |
| Dec 29, 2023 | 4.07B | 0.96% |
| Dec 30, 2022 | 4.03B | -40.71% |
| Dec 31, 2021 | 6.80B | -49.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.48B |
| Beijing Strong Biotechnologies,Inc. | 7.30B |
| Maccura Biotechnology Co.Ltd | 6.95B |
| Cowealth Medical China | 6.49B |
| Thalys Medical Technology Group | 4.78B |
| SMO ClinPlus CO.,LTD. | 4.37B |
| Guangdong Hybribio Biotech | 4.24B |
| Shanghai Labway Clinical Laboratory | 4.14B |